Capricor Therapeutics (CAPR) Institutional Ownership $4.59 +0.41 (+9.81%) (As of 05:16 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Capricor Therapeutics (NASDAQ:CAPR)CurrentInstitutional OwnershipPercentage21.68%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$2.92MNumber ofInstitutional Sellers(last 12 months)0 Get CAPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Capricor Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CAPR Institutional Buying and Selling by Quarter Ad Porter & CompanyWar on Elon Escalates… Elon Musk just built a supercomputer in Memphis, Tennessee. It took him only 122 days. Dubbed “Colossus,” this supercomputer aims to become the most powerful AI training system in the world. Housed in a 785,000 sq. ft facility in Memphis, Colossus will soon require 150 megawatts of electricity per day. That’s about equal to the amount of energy needed to power 100,000 homes per year. Click here and take notes. Capricor Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2024 Marshall Wace LLP89,314$426K0.0%N/A0.279% 8/9/2024 Renaissance Technologies LLC137,500$656K0.0%+158.7%0.430% 8/8/2024 Main Street Financial Solutions LLC27,500$131K0.0%+37.5%0.086% 8/1/2024 Rhumbline Advisers30,886$147K0.0%N/A0.097% 7/26/2024 Bank of New York Mellon Corp79,782$381K0.0%+12.8%0.249% 5/10/2024 Vanguard Group Inc.1,365,903$9.27M0.0%+17.2%4.336% Get the Latest News and Ratings for CAPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Capricor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/1/2024 BNP Paribas Financial Markets5,827$40K0.0%N/A0.018% 2/7/2024 Jump Financial LLC52,800$258K0.0%N/A0.171% 12/6/2023 Citigroup Inc.61,591$211K0.0%N/A0.200% 7/31/2023 LPL Financial LLC78,436$375K0.0%N/A0.310% 5/1/2023 Virtu Financial LLC16,895$71K0.0%N/A0.067% 11/7/2022 Jump Financial LLC22,600$136K0.0%N/A0.093% 10/18/2022 Bailard Inc.33,601$202K0.0%+12.8%0.138% 7/27/2022 Bailard Inc.29,801$104K0.0%N/A0.123% 4/20/2022 Selective Wealth Management Inc.213,494$732K0.3%N/A0.878% 11/16/2021 Two Sigma Securities LLC11,511$46K0.0%N/A0.050% 11/15/2021 GSA Capital Partners LLP96,632$388K0.0%-14.0%0.420% 11/15/2021 HighTower Advisors LLC53,960$215K0.0%+206.6%0.234% 11/9/2021 Barclays PLC6,330$25K0.0%+246.1%0.027% 11/9/2021 BlackRock Inc.300,201$1.21M0.0%-1.6%1.304% 8/17/2021 Oracle Investment Management Inc.1,166,249$5.98M0.8%-41.7%5.098% 8/16/2021 State Street Corp71,748$368K0.0%N/A0.314% 8/13/2021 Northern Trust Corp104,251$535K0.0%+7.5%0.456% 8/13/2021 Geode Capital Management LLC184,990$948K0.0%+7.9%0.809% 8/13/2021 Vanguard Group Inc.923,233$4.74M0.0%+1.2%4.035% 8/11/2021Susquehanna Fundamental Investments LLC16,500$85K0.0%-49.1%0.072% 8/5/2021 GSA Capital Partners LLP112,364$576K0.1%+684.6%0.491% 5/18/2021 Millennium Management LLC22,390$105K0.0%-54.6%0.098% 5/18/2021 Oracle Investment Management Inc.1,999,464$9.36M1.4%N/A8.770% 5/12/2021 Northern Trust Corp96,941$453K0.0%-29.1%0.425% 5/12/2021 M Holdings Securities Inc.20,000$94K0.0%N/A0.088% 5/12/2021 Geode Capital Management LLC171,415$802K0.0%+40.7%0.752% 5/10/2021 HighTower Advisors LLC12,300$57K0.0%-25.9%0.054% 5/10/2021 GSA Capital Partners LLP14,321$67K0.0%-81.9%0.063% 5/7/2021 BlackRock Inc.347,103$1.62M0.0%+1.2%1.523% 5/3/2021Trellus Management Company LLC270,000$1.26M0.7%N/A1.184% 2/11/2021 Northern Trust Corp136,814$469K0.0%-9.6%0.669% 2/9/2021 Bank of New York Mellon Corp89,249$306K0.0%+47.7%0.436% 2/5/2021 BlackRock Inc.343,011$1.18M0.0%+0.4%1.677% 2/4/2021 GSA Capital Partners LLP79,091$271K0.0%N/A0.387% Place this $0.99 trade BEFORE the election (Ad)Earlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands of traders and placed a unique trade that surged 1,129% in just 2 days... All using a unique trade that cost him less than $0.99 trade.Click here to RSVP to today's FREE training >>>11/17/2020 Jane Street Group LLC12,943$68K0.0%-51.1%0.066% 11/13/2020 Morgan Stanley44,843$235K0.0%+26.4%0.227% 11/12/2020 JPMorgan Chase & Co.5,607$30K0.0%+80,000.0%0.028% 11/6/2020 BlackRock Inc.341,523$1.79M0.0%+900.8%1.732% 9/15/2020 Two Sigma Advisers LP21,130$97K0.0%N/A0.107% 8/17/2020 Jane Street Group LLC26,474$122K0.0%+9.6%0.134% 8/12/2020 Goldman Sachs Group Inc.38,808$179K0.0%N/A0.272% (Data available from 1/1/2016 forward) CAPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CAPR shares? During the previous two years, 12 institutional investors and hedge funds held shares of Capricor Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($9.27M), Renaissance Technologies LLC ($656K), Marshall Wace LLP ($426K), Bank of New York Mellon Corp ($381K), LPL Financial LLC ($375K), Jump Financial LLC ($258K), and Citigroup Inc. ($211K).Learn more on CAPR's institutional investors. What percentage of Capricor Therapeutics stock is owned by institutional investors? 21.68% of Capricor Therapeutics stock is owned by institutional investors. Learn more on CAPR's institutional investor holdings. Which institutional investors have been buying Capricor Therapeutics stock? Of the 12 institutional investors that purchased Capricor Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vanguard Group Inc. ($200.50K), Marshall Wace LLP ($89.31K), Renaissance Technologies LLC ($84.35K), LPL Financial LLC ($78.44K), Jump Financial LLC ($75.40K), Citigroup Inc. ($61.59K), and Rhumbline Advisers ($30.89K). How much institutional buying is happening at Capricor Therapeutics? Institutional investors have bought a total of 663,538 shares in the last 24 months. This purchase volume represents approximately $3.53M in transactions. Related Companies: CLSD Institutional Ownership LPTX Institutional Ownership PRPH Institutional Ownership EYEN Institutional Ownership NRBO Institutional Ownership GLMD Institutional Ownership PHVS Institutional Ownership SIGA Institutional Ownership ARCT Institutional Ownership KALV Institutional Ownership This page (NASDAQ:CAPR) was last updated on 9/13/2024 by MarketBeat.com Staff From Our PartnersWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredYou won’t believe what this ex-Wall Street insider discovered about the electionOne ex-Wall Street insider recently combed through 64 years of election data… And he just uncovered somethi...Banyan Hill Publishing | Sponsored Turn Smartphones Into “Earnphones”?High-Growth Smartphone Startup 45 Million Users. $60M+ in Revenue. 32,481% Growth Rate. $1T+ market opportu...Mode Mobile | SponsoredPlace this $0.99 trade BEFORE the electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredTiny Defense Firm Set for Huge Gains with New US ContractOne tiny defense firm just won a groundbreaking US military contract… That could hand early investors gains...Behind the Markets | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capricor Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Capricor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.